MIXED CONNECTIVE TISSUE DISEASE TREATMENT

(MCTD) Mixed connective tissue disease is an uncommon, specifically defined syndrome characterized by clinical features of systemic lupus erythematosus, systemic sclerosis, and polymyositis with very high titers of circulating antinuclear antibody to a ribonucleoprotein antigen.

SYMPTOMS: - Hand swelling, Raynaud syndrome, polyarthralgia, inflammatory myopathy, esophageal hypomotility, and interstitial lung disease are common. Diagnosis: is by the combination of clinical features, antibodies to ribonucleoprotein, and absence of antibodies specific for other autoimmune diseases. Symptoms and Signs of MCTD --Raynaud syndrome (Raynaud phenomenon) may precede other manifestations by years. Frequently, the first manifestations resemble early SLE, systemic sclerosis, polymyositis, or even rheumatoid arthritis. Many patients appear to have an undifferentiated connective tissue disease initially. The disease manifestations may progress and become widespread, and the clinical pattern changes over time.

Initial, diffuse swelling of the hands is typical but not universal. Skin findings include lupus or dermatomyositis-like rashes. Diffuse systemic sclerosis–like skin changes and ischemic necrosis or ulceration of the fingertips may develop. Testing for antinuclear antibodies (ANA), antibodies to extractable nuclear antigen (antibodies to U1 ribonucleoprotein, or RNP), and Smith (Sm) and anti-DNA antibodies

Organ involvement determined as clinically indicated.

CONCLUSION: - Any type of connective tissue disorder can easily be managed and the disease progression can be prevented by Homoeopathic remedies.